0

Hemophilia Gene Therapy - A Pipeline Analysis Report

  • Published: Oct 2017
  • Pages: 105
  • SKU: IRTNTR15465
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

This pipeline analysis report identifies uniQure, Alnylam Pharmaceuticals, BioMarin Pharmaceutical, Spark Therapeutics, Shire, and Sangamo Therapeutics as some of the companies that are actively involved in the development of gene therapy molecules for hemophilia patients. This report presents a comprehensive analysis of the therapeutic assessment by therapy (monotherapy and combination therapy), by ROA (intravenous, subcutaneous, and unspecified), and by stage and ROA (phase III, phase I/II, phase I and IND, and pre-clinical). This pipeline analysis report also provides a detailed analysis of hemophilia gene therapy based on indications such as hemophilia A and hemophilia B.

Overview of the pipeline analysis report on hemophilia gene therapy

Hemophilia is an ideal genetic disorder and the drawbacks with the majority of the standard protein substitution therapy drugs resulted in the shift in interest towards the development of alternative treatments by gene therapy. Though the risk of developing antibodies to the viral vectors that are used to deliver the genetic material to the cells poses as a major drawback to gene therapy, the rising commercial importance of the gene therapy approach for the treatment of hemophilia resulted in a rise in the number of collaboration agreements between industries and research institutes.  For instance, the acquisition of Baxalta helped the specialty pharmaceutical company become the largest hemophilia player and the company has announced that it has generated a revenue of more than USD 870 million in 2016.

According to Technavio’s pipeline analysis report on hemophilia gene therapy, the pipeline molecules in hemophilia gene therapy are currently in the pre-clinical development stage.  SHP648, a high-performing next-generation FIX gene therapy candidate from one of the major Tier I companies Shire, is currently in the pre-clinical stage and the development of this therapeutic candidate is based on the AAV8-based gene therapy technology.

Key companies

Technavio’s analysts have identified thirteen companies that are actively involved in the development of gene therapy for hemophilia patients. Based on the companies’ revenue, this report has segregated the players into Tier 1, Tier 2, and Tier 3 companies. One of the major Tier 1 companies Alnylam Pharmaceuticals, is a leading player in the biotechnology industry and has registered an income of more than USD 410 million.

The Tier 1 companies covered in this report are –

  • uniQure
  • Alnylam Pharmaceuticals
  • BioMarin Pharmaceutical
  • Spark Therapeutics
  • Shire

Segmentation of hemophilia gene therapy molecules by indication

  • Hemophilia A
  • Hemophilia B

It has been observed that the prevalence of hemophilia A is more in the US and the countries in EU5 such as France, Germany, Italy, Spain, and United Kingdom. According to this pipeline analysis report, most of the companies that are involved in the development of gene therapy for hemophilia patients are currently focusing on developing drugs for hemophilia A.

Therapeutic assessment of the hemophilia gene therapy molecules based on therapy

  • Monotherapy
  • Combination therapy

Monotherapy is the utilization of a single drug to treat a disease. Our research analysts have identified that all the hemophilia pipeline drugs that are currently in the pipeline are being developed only as a monotherapy agent and most of these molecules are still in the pre-clinical phase.

Key questions answered in the report include

  • What are the different stages of the pipeline molecules in investigation?
  • What are the molecules in the various development stages in the hemophilia gene therapy pipeline?
  • What are the key companies that are currently involved in the development of gene therapy drugs for hemophilia?
  • What are the molecules discontinued from the hemophilia gene therapy pipeline?
  • What are the major regulatory authorities approving drugs in various regions?

Technavio also offers customization on reports based on specific client requirement.

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION

PART 05: MAJOR REGULATORY AUTHORITIES

  • US
  • Europe
  • China

PART 06: PIPELINE LANDSCAPE

PART 07: COMPARATIVE ANALYSIS

  • Discovery stage molecules
  • Pre-clinical stage molecules
  • Inactive and discontinued molecules

PART 08: INDICATION ANALYSIS

PART 09: THERAPEUTIC ASSESSMENT (THERAPY BASED)

PART 10: THERAPEUTIC ASSESSMENT (ROA BASED)

PART 11: THERAPEUTIC ASSESSMENT BY TARGET

PART 12: KEY COMPANIES

  • Active companies: Category and parameters

PART 13: APPENDIX

  • List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>